Emerald Laser – The Future of Fat Loss Webinar | EMPIRE MEDICAL

GLYNIS REINA ABLON, M.D., F.A.A.D.
Associate Clinical Professor U.C.L.A.
Ablon Skin Institute and Research Center
1600 Rosecrans Ave. 4B
Manhattan Beach, Calif. 90266
(310) 727-3376 office
www.abloninstitute.com
Drablon@abloninstitute.com

PERSONAL:

Birthplace: Los Angeles, CA.
Board Certified in Dermatology
Oct. 1996, recertification 2005, 2016
ABD #012931
Fellowship Oculoplastic Surgery 1999

EMPLOYMENT: Dermatology and Cosmetic Surgery

Ablon Skin Institute & Research Center: 1600 Rosecrans, 4B, MB, CA. Aug 2001 to present
Associate, Little Co. of Mary: 1010 N. Sepulveda; Manhattan Bch, CA. 90266. April 1997-2003
Associate, Beverly Hills Med. Mgt.: 8641 Wilshire Blvd; B.H. CA. 90211. Sept 1996 to March 1997

HOSPITAL AND TEACHING PRIVILEGES:

UCLA- VA: Associate Clinical Professor

Providence Little Company of Mary Hospital:  Courtesy staff

CERTIFICATIONS:

Recertification Good Clinical Practice Training – NIH web-based certification on “Protecting Human Research Participants,” June 2020
Recertification Advanced Cardiac Life Support, June 2020
Recertification Basic Life Support, June 2020

EDUCATION:

Fellowship Oculoplastic surgery, Sinsky Eye Institute, 2222 Santa Monica Blvd. #107, Santa Monica, CA 90404. July 1999 to Dec. 1999, Dr Guy Massry (310) 657-4302
Residency: Dermatology at Baylor College of Medicine, One Baylor Plaza, Houston, Tx. 77030 (713)798-4951. July 1993 to July 1996
Internship: Internal Medicine at Cedars Sinai Medical Center, 8700 Beverly Blvd. West Hollywood, CA 90048. (310) 423-3277.July 1992 to July 1993
Medical School: The George Washington University, 2121 I Street NW, Washington, D.C. 20052. (202) 994-1000. Aug. ‘88 to May ‘92, M.D degree
Undergraduate: Pomona College, The Claremont Colleges, Claremont, CA. (909) 621-8000.September 1984 to May 1988 Bachelor of Arts (French Literature), Cum laude.
High School: Westlake School for Girls, Beverly Hills, CA. September 1978 to June 1984. Cum Laude with departmental honors in Mathematics and French, Dean's Honor List.

COSMETIC SURGERY CERTIFICATIONS:

Laser certification: Sharplan Silktouch/Feathertouch Carbon laser (CO2), Tru-pulse CO2 laser, Coherent Ultrapulse CO2, Versapulse, and Diode lasers, Erbium Yag laser, Photoderm ESC, Candela Gentlelase hair removal laser, Q-switched Ruby, Vasculight, Sciton(Nd-Yag), Titan, Thermage, E-Matrix, Velashape, Endermology, Pulsed Dye Laser ,Zeltiq,     Zerona, Tripolar, Endymed, Venus Viva, ThermiRF, ThermiVA , Lunula, Excel V

Residency laser training: Candela dye laser, Q-Switch Yag laser, Continuous wave CO2 laser. Photoderm Liposuction surgery certification: liposuction and ultrasound-assisted liposuction, lipotransfer, Bodyjet Residency training: sclerotherapy, collagen/fillers injections, scar revisions, botulinum toxin

RESEARCH:

2021:

1. .A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients with Moderate to Severe Atopic Dermatitis, Extension Study, Eli Lilly, Ablon et al.
2. A Phase 2, Multicenter, Randomized, Double-blind, Vehicle Controlled Clinical Study to Compare the Safety and Efficacy of IDP 126 Gel to Epiduo Forte Gel in the Treatment of Acne Vulgaris, Bausch, Ablon et al.
3. A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients with Moderate to Severe Atopic Dermatitis. Eli Lily, Ablon et al.
4. A Supplement for the Treatment of Male Pattern Hairloss. Nutrafol, Ablon & Bhatia

2020:     1. A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients with Moderate to Severe Atopic Dermatitis, Eli Lilly, Ablon et al.

2..QM Program Lateral Canthal Lines Investigational Trial, 43QM1901, Galderma, Ablon et al.

3. A Phase 2, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Combined Treatment of Upper Facial Lines. Revance, Ablon et al.
4. A Prospective, Multicenter, Randomized, Double-blind, Vehicle-controlled Phase 2 Study to Evaluate the Safety and Efficacy of a Combination of 3% Minocycline and 0.3% Adapalene Topcial Foam Formulation for the Treatment of Moderate to Severe Acne. Foamix, Ablon et al.
5. A Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Anti-aging Serum in the Treatment of Facial Lines in Women Ages 35-60. Revision, Ablon et al.
6. A Randomized, Double-blind, Placebo-controlled study Evaluating the Ability and Safety of a Nutraceutical Supplement with Standardized Botanicals to Promote Hair Growth in Perimenopausal, Menopausal, and Post-menopausal Women with Self-perceived Thinning Hair. Nutrafol. Ablon et al.

2019:     1. A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurtiva. ChemoCentryx. Ablon et al.

2. A Randomized, Double-blind, Placebo-controlled study Evaluating the Ability and Safety of a Nutraceutical Supplement with Standardized Botanicals to Promote Hair Growth in Perimenopausal, Menopausal, and Post-menopausal Women with Self-perceived Thinning Hair. Nutrafol. Ablon et al.
3. A Randomized, No-Treatment Controlled, Evaluator-Blinded, Multi-Center Study to Evaluate the Effectiveness and Safety of Restylane® Defyne in the Chin for Augmentation and Correction of Chin Retrusion.” Galderma, Ablon et al.
4. A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects. Valeant, Ablon et al.
5. A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines. Q-Med AB, Ablon et al.
6. A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris. Valeant, Ablon et al.
7. Phase 3, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, 2 Arm study to assess the safety and efficacy of S6G5T-3 cream compared to S6G5T-8 vehicle cream in the treatment of acne vulgaris. Sol-Gel Tech., Ablon, et al.

2018:     1. A Phase 3, An Open‐Label, Multi‐Center Trial to assess the Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection to Treatment of Moderate to Severe Glabellar Lines. Revance. Ablon et al.

2. A Randomized, No-Treatment Controlled, Evaluator-Blinded, Multi-Center Study to Evaluate the Effectiveness and Safety of Restylane® Defyne in the Chin for Augmentation and Correction of Chin Retrusion.” Galderma, Ablon et al.
3. A Mutlitcenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical Minocycline Gel(HY01) in Patients with Papulopustular Rosacea, Hovione. Ablon et al.
4. A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects. Valeant, Ablon et al.
5. Clarisonic Study, Ablon et al.

6.A Phase 3, Double-blind, Vehicle-controlled, Randomized, Parallel Group, Multicenter, Efficacy and Safety Study of KX2-391 Ointment 1% in Adult Subjects with Actinic Keratosis on the Face or Scalp. Athenix. Ablon et al.

2017:     1. A Phase 3, An Open‐ Label, Multi‐Center Trial to assess the Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection to Treatment of Moderate to Severe Glabellar Lines. Revance. Ablon et al.

2. A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202(Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat. Neothetics, Ablon et al
3. A 6 Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of Nutrafol Supplement to Promote Hair Growth in Women with Self-Perceived Thinning Hair. Nutraceutical Wellness, Ablon
4. A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-123 Lotion and IDP-123 Vehicle Lotion in the Treatment of Acne Vulgaris. Valeant, Ablon et al.

2016:     1. A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris. Valeant, Ablon et al

2.A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects with Papulopustular Rosacea with a 4 Week Follow-up Period. Cutanea Sciences, Ablon et al.

3. Silouette Instalift study. Ablon, Lorenc, Mandy, Nestor, in progress
4. Open label, single center, evaluating the effectiveness of an automated microneedling device in improving the signs of aging. Ablon. In progress

2015:     1. Clinical Evaluation of the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing, Multi-Center Site Study, Ablon et al  

2.A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat in Non-Obese Subjects, Ablon et al

3. A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat in Obese Subjects, Ablon et al
4. Evaluation of Cellulation Acne Masks with a PRN roll-on treatment in subjects with mild to      moderate acne, Ablon, Gold & Werschler in progress

2014:     1. A 6 month Double-Blind Placebo Controlled Clinical Trial for Men’s Self Perceived Hair Loss Using Viviscal Extra-Strength Formulation, Ablon

2013:     1. A 3-month, Randomized, Double-Blind Placebo-Controlled Study Evaluating the Ability of a New Viviscal Extra-Strength Formulation to Promote Hair Growth and Decrease Shedding in Women with Self-perceived Thinning Hair, Ablon

2. Multicenter Study of Viviscal Professional Strength Oral Supplement in Females with Self-Perceived Thinning Hair, Ablon, Dayan submitted for publication
3. Open Label, Non-randomized, Multicenter, Prospective Trial for ReGenica Post Procedure Pot Marketing Study, Ablon et al

2012:     1. A Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy of Viviscal Professional Strength Oral Supplement in Females with Self-Perceived Thinning Hair , Ablon

2011:      1.  A Randomized Double Blind, Vehicle Controlled Pilot Study to Assess the Efficacy of 3.5 % Benzoyl Peroxide Formulated in a Novel Delivery System in the Treatment of Moderate to Severe Acne Vulgaris, Nestor and Ablon, in progress

2.A Randomized Double Blind, Vehicle Controlled Pilot Study to Assess the Efficacy of 2% Hydroquinone Formulated in a Novel Nano Technology Delivery System in the Treatment of Moderate to Severe Melasma, Nestor and Ablon, in progress

2010:      1. A Multisite Clinical Study Designed to Assess and Document a New Fat Harvesting and Autologous Fat Grafting Procedure, Nestor and Ablon, in progress

2. A Randomized Double Blind, Vehicle Controlled Pilot Study to Assess the Efficacy of 21/2 % Benzoyl Peroxide Formulated in a Novel Delivery System in the Treatment of Moderate to Severe Acne Vulgaris, Nestor and Ablon, in progress
3. A Randomized Double-Blind, Vehicle-Controlled Pilot Study to Assess the Efficacy of Topically Applied OnabotulinumtoxinA (Botox), AbobotulinumtoxinA (Dysport) and RimabotulinumtoxinB (Myobloc) in the Treatment of Hyperhidrosis Using a Novel Transdermal Delivery System, Nestor and Ablon, submitted for publication
4. A Randomized, Double-Blind, Clinical Study Designed to Assess the Onset, Efficacy and Safety of AbobotulinumtoxinA (Dysport), versus OnabotulinumtoxinA (Botox) in the Treatment of Dynamic Rhytids of the Frontalis (Individual Subject Contralateral Injection Sites) Utilizing the Objectve Frrontalis Activity Measurement Standard, Nestor and Ablon.

2009:     1. Evaluation of the Efficacy and Tolerance of Transdermal CL1 versus Non-CL1 in the appearance of photodamaged skin, Nestor and Ablon, submitted for publication

2. Use of Topical Lidocaine Nano Technology Delivery System to Reduce Patient Discomfort

Associated with Dermal Filler Injections, Nestor and Ablon submitted

3. The Use of a Novel Contact Cooling Device to Reduce Pain and Eccymosis Associated with

Dermal Filler Injections, Nestor and Ablon.

4. Novel Topical Rosacea Treatment. Nestor and Ablon

2008:     1. A Double-Blinded, Randomized Clinical Evaluation of the Efficacy of Tested Sunscreens in Maintaining the Depigmenting Benefits of Laser and Light Treatments on Melasma Patients, Nestor and Ablon, submitted for publication

2005:     1. The Treatment of Submental Fat Pads with Phosphatidylcholine, Ablon in progress

2004:     1. Deoxycholate Injections for the Treatment of Lipomas. Rotunda, and Ablon

2003:     1. Phosphatidylcholine injections for lower lid fat pads, Ablon

2000:     1. The Pumpkin Peel (chemical masque). Glynis Ablon and Lawrence Moy in progress

1999:     1. Treatment of Darier’s Disease with Pulsed CO2 laser. G. Ablon, Nicolas Lowe

1997:     1. Non-melanoma skin cancers and suspicious pigmented lesion: Skin cancer screening and                             evaluation of 600 California lifeguards. G. Ablon, M.D., Paul Silka M.D., John Kim in progress. 1996: 1. Vancomycin induced linear IgA dermatoses, a case report. G.Ablon, S.Lambert, and S Bruce.

2. Sarcoidosis: literature review and retrospective study of treatment modalities. Ablon, Rosen
3. Generalized Actinic Comedonal Plaques: a Case report and new treatment option. Glynis                            Ablon, and Ted Rosen, work in progress

1994:     1.  A Multi-center, Single-Blind Clinic Trail to determine the Efficacy of Dermagraft, a Living

Dermal Replacement, in Treatment of Full-thickness chronic Venous Insufficiency Ulcers.

Study completed in cooperation with Advanced Tissue Sciences, Inc. Ablon, Bruce, & Wolf.

2. A Randomized Multi-Center Trail Comparing the Safety and Efficacy of Telio-Derm with

Saline control in Patients with Venous Leg Ulcers. Ablon and Rosen.

3. Optical Fiber Spectrometer Measurements on Skin: Detecting Vessel Depths. Glynis Ablon,

Steve Jaques, Ph.D., and Ted Rosen, M.D., work in progress.

1992:     1. Research and clinical dermatology elective. Hospital Saint-Louis, with Dr. Antoine Puissant                      and Dr. Patrice Morel, Paris, France, publications pending (one has since been published).

1991:     1. Progesterone Induced Autoimmune Dermatitis. Glynis Ablon and C. Myrie-Williams M.D.,

2. Clinical Serological Evidence of Ovarian Hyperandrogenism in Diabetic Females. Glynis                Ablon and Dr. Ratner GWU Dept. of Endocrinology. Work continues.
3. Hirsutism Variations Among Ethnic Populations. Glynis Ablon, and Dr. Ratner, Manuscript

revisions, expand patient population, under publisher’s request.

1987:     1. Genetics Research. Advisor Larry Cohen, Ph.D. Pomona College Dept. of Genetics;

RNA isolation for cloning and sequencing of the kiwi enzyme actinidin.

2. Determination of maturation stages of papaya for papain enzyme isolation through the

technique of dot blots, southern blot, and affinity columns. Work still in progress by lab.

Publications:

1. Marcus, Ablon, et al. A Randomized Trial to Assess Effectiveness and Safety of a Hyaluronic Acid Filler for Chin Augmentation and Correction of Chin Retrusion. PRS. Accepted for publication
2. Joseph, Ablon, Et al. AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study. JDD Sep 2021. 20(9): 980-7.
3. Dermatologic Clinics Hair Issue, Nutraceuticals Chapter Dr Ablon, Editor Neil Sadick July 2021
4. Nguyen,Zahr,Ablon, A Randomized, Double-blind, Placebo controlled Clinical Study Investigating the Efficacy and Tolerability of a Peptide Serum Targeting Expressin Lines. JCAD, May  2021, vol 14(5):14-21.
5. Green, Coleman, Mariwalla, Weinkle and Ablon. A Large, Open-Label, Phase 3 Safety Study of Daxibotulinumtoxin A for Injection of Glabellar Lines: A Focus on Safety from the SAKURA 3 Study. Derm Surg Jan 2021: 42-46.
6. Ablon, Kogan. A Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Perimenopausal, Menopausal and Postmenopausal Women with Self-Perceived Thinning Hair. JDD. Jan 2021. 20(!):55-61
7. Blauvelt, Kempers, Lain, Tyring, Ablon, et al. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis. NEJM 2020 accepted for publication.
8. Nolda, Ablon. Safety and Effectiveness of an Automated Microneedling Device in Improving Acne Scarring. JCAD Nov 2020
9. Gold, Ablon, et al. A Cohort Study Using a Facial Cleansing Brush with Acne Cleansing Brush Head and a Gel Cleanser in Subjects with Mild-to-moderate Acne and Acne-prone Skin. JDD Nov 2019 18(11): 1140-1145.
10. Gold, Ablon, et al. Facial Cleansing with a Sonic Brush – A Review of the Literature and Current Recommendations. J Cosmet Derm Jan 2019: 1-6
11. Del Rosso, Harper, Kircik, Ablon, et al.  Consensus Recommendations on Adjunctive Topical Management of Atopic Dermatitis. Ablon. JDD Oct 2018, 11(10):
12. Ablon. Safety and Effectiveness of an Automated Microneedling Device in Improving the Signs of Aging Skin. JCAD Aug 2018, 11(8): 33-38.
13. Lorenc, Ablon, et al. Expert Consensus on Achieving Optimal Outcomes with Absorbable Suspension Suture Technology for Tissue Repositioning and Facial Recontouring. JDD June 2018, 17(6): 647-655
14. Ablon, Kogan. A 6-month Randomized, Double-blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women with Self-perceived Thinning Hair. JDD May 2018, 17(5):558-565
15. Ablon. Phototherapy with Light Emitting Diodes: Treating a Broad Range of Medical and Aesthetic Conditions in Dermatology. JCAD 2018, 11(2):21-7.
16. Nestor,Andriessen,Berman,Katz,Day,Gilbert,Goldberg,Ablon,et al. Photobiomodulation with  Non-Thermal Lasers: Mechanism of Action and Therapeutic Uses in Dermatology and Aesthetic Medicine. Submitted JDD
17. Nestor, Ablon, Andriessen, Few et al. Expert Consensus on Absorbable Advanced Suspension Technology for Facial Tissue Repositioning and Volume Enhancing Treatment.  JDD July 2017 16(7):661-6.
18. Berman, Ablon, Bahtia, et al. Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratoses. JDD March 2017 vol 16(3):611-16.
19. Ablon G: A 6-month, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Ability of a Marine Complex Supplement to Promote Hair Growth in Men with Thinning Hair. JOCD August 2016 http://dx.doi.org/10.1111/jocd.12265
20. Nestor, Ablon, Pickett: Key Parameters of Abobotulinumtoxin A in Aesthetics-Onset and Duration. Aesth Surg Journal May 2017, 37 (supp 1):s20-26
21. Ablon G: Understanding How to Prevent and Treat Adverse Events of Fillers and Neuromodulators, Plastic and Resconstructive Surgery Journal Sept 2016.
22. Ablon G, Dayan S: Multicenter Extension Study of Viviscal Professional Strength Oral Supplement in Females with Self-Perceived Thinning Hair,  JCAD Dec 2015, vol 3(12):20-26
23. Ablon, Glynis. What’s Stressing Your Face.  Basic Health Publications, Sept 2015.
24. Ablon. A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair, Dermatology Research and Practice. April 2015
25. Ablon. Brief Overview of Viviscal Supplements for Hair Loss. Practical Dermatology, July 2013
26. Ablon.  A Double Blind Placebo-controlled Study Evaluating the Efficacy of an Oral Supplement JCAD, Nov 2012, Vol 5 (11): 28-34
27. Nestor, Ablon.  Comparing the Clinical Attributes of AbobotulinumtoxinA and OnabotulinumtoxinA Utilizing a Novel Contralateral Frontalis Model and the Frontalis Activity Measurement Standard.  Journal of Drugs and Dermatology, Oct 2011, Vol 10(10): 1148-1157
28. Nestor, Ablon.  Duration of Action of Abobotulinumtoxin A and Onabotulinumtoxin A:  A Randomized, Double Blind Study Using a Contralateral Frontalis Model.  Journal of Aesthetic and Cosmetic Dermatology, Sept 2011, Vol. 4(9):  43-49.
29. Nestor, Ablon.  The Frontalis Activity Measurement Standard:  A Novel Contralateral Method for Assessing Botulinum Neurotoxin Type-A Activity.  Journal of Drugs in Dermatology. Sept 2011, Vol 10 (9): 968-972
30. Ablon, G, Nestor, M: Minimum Recovery Procedures, In: Aesthetic Rejuvenation Challenges and Solutions: A World Perspective, Eds; Carniol, PJ, Monheit, G, London, 2009
31. Natural Solutions, November 2010 issue “Diabetic Skin Concerns,” Ablon
32. Nestor, Ablon, Collins.  A Double-Blind Vehicle-Controlled Trial to Investigate the Efficacy and Tolerance of Transdermal CL1 (Restylane) Versus Non-CL1 (Non-Cross-Linked HA) in the Appearance of Photodamaged Skin. Submitted for publication 2010
33. Nestor, Ablon.  The use of a Novel Contact Cooling Device to Reduce Pain and Ecchymosis Associated with Dermal Filler Injections, JCAD March 2010, Vol., No.3: 29-34.
34. Glynis Ablon. Combination 830nm and 633nm LED phototherapy shows promise in the treatment of recalcitrant psoriasis: preliminary findings. Journal of Photomed and Laser, 28(1)Feb 2010.
35. Glynis Ablon. Dissolving the Double Chin. Journal of Dermatol Surgery, submitted for public.
36. Glynis Ablon:  The Pocket Mentor: Rx for Starting Your Own Successful Medical Practice, published 7/06
37. A. Rotunda, Glynis Ablon, M. Kolodney. Lipomas Treated with Subcutaneous Deoxycholate Injections.  Journal of the American Academy of Dermatology. Dec.2005, 53(6): 973-978
38. Glynis Ablon, A. Rotunda. Phosphatidylcholine Injections for Lower Lid Fat Pads. Journal of Dermatologic Surgery March 2004, 30(3): 422-427
39.  Glynis Ablon, T. Rosen.  Cutaneous Herpesvirus Infection Update: Part 1.  Consultant. Aug. 1997, 37 (8): 2021-2042.
40. Glynis Ablon, T. Rosen. Cutaneous Herpesvirus Infection Update: Part 2 and 3. Consultant.Sept. 1997, 37 (9): 2443-2455, 2459-2463.
41. Glynis Ablon. Sun Damage and Sunscreen.  Goodnews Health and Fitness.  Summer 1997:  20.
42. Glynis Ablon and Ted Rosen. Cutaneous Signs of Systemic Disease: A Guide to Gleaming Diagnostic Clues from the Skin. Consultant. Apr. 1994, 34 (4): 495-512.
43. Glynis Ablon and Ted Rosen. Bacterial Skin Infections: Diagnostic Clues and Treatment Choices. Consultant, Nov. 1994, 34 (11): 1525-1542.
44. Glynis Ablon and Ted Rosen. Protozoan Skin Infections: The World Traveler and the Unwanted.

Companion. Consultant. Apr. 1995, 35 (4): 461-468.

1. G. Ablon and Ted Rosen. A Comparative Study of Three New Topical Antifungal Medications

International Journal of Dermatology, July 1996.

1. C. Lebbe, M. Rybojad, G. Ablon, P. Morel, Extensive Human Papilloma Virus - Related Disease (Bowenoid Papulosis, Bowen's Disease, and Squamous Cell Carcinoma) in a Pt with Hairy Cell Leukemia: Clinical and Immunology Evaluation after an Interferon-alpha Trial. Journal Amer Acad Dermatol. Oct. 1993, 29 (4): 644-646.
2. G. Ablon, Rosen. Travel-Related Helminthic Skin Infections.Consultant.May '95, 35(3): 631-9
3. G. Ablon, C. Myrie-Williams, Necrobiosis Lipoidica: A Novel Treatment Approach. Submitted
4. C. Lebbe, G. Ablon, et al. Dermatomyositits and Cyanoacrylate Exposure. Submitted
5. C. Lebbe, G. Ablon, et al. Thalidomide for the Treatment of Apthous Ulcers in HIV. Submitted

MAGAZINE AND NEWSPAPER PUBLICATIONS:

1. Hollywood Reporter, Top 27 Docs: Aug 2021
2. Elle Magazine, Hair loss, 2015
3. Woman’s Day Journal, Hair loss, 2014
4. Japanese Magazine, Sciton Laser. Sep 2014
5. Wallstreet Journal, September 3,2013, “Melafind”
6. Orange County Register, June 2013, “Melafind”
7. VIV Magazine, online, summer 2013
8. Shape Magazine June 2010: “Cellulite”
9. Allure Magazine, 2009: “Nanotechnology Research”
10. Prevention Magazine: 2007 “Cellulite”
11. LA Times, 2006: “Economic Times Impact on Cosmetic Surgery”
12. LA Times, 2004:” STD’s”

PRESENTATIONS/ TELEVISION APPEARANCES:

1. South Beach Symposium, Florida: Session Director Hair Restoration Track, 2/22
2. NAMS, DC: Menopause and Supplements abstract poster, 9/21
3. South Beach Symposium, Florida: PRP vs Transplant, 9/21
4. South Beach Symposium, Florida: Scarring vs Nonscarring Alopecia, 9/21
5. South Beach Symposium, Florida: Low Level Laser and Alopecia, 9/21
6. South Beach Symposium, Florida: JAK inhibitors and Hair loss, 9/21
7. South Beach Symposium, Florida: Chin Injection Techniques , 9/21
8. South Beach Symposium, Florida: Subtle yet effective: Lip Enhancement Anatomy and injection workshop  9/21
9. NBC News Today in LA: Covid and Supplements 9/21
10. NBC News Today in LA: Covid and Hair Loss, 7/21
11. Extra TV, What’s Stressing Your Face, 6/21
12. Maui Derm NP + PA meeting, CO: abstract/poster: Efficacy and Safety of Tazarotene 0.0454% Lotion in Female Patients with Moderate to Severe Acne. 6/21
13. NBC News, Today in LA: “Covid Rashes,” 4/21
14. NBC News 5 pm: “Covid Rashes,” 4/21
15. ASAPS 2021 virtual meeting: abstract presentation: DAXI for Mature Females 5/21
16. AAD VMX 2021 virtual meeting: abstract presentation: DAXI for Mature Females 4/21
17. NBC News, Today in LA: “Winter Skin on a Budget,” 2/21
18. Virtual Meeting JDD, Menopausal women and hairloss: Nutrafol Balance, 2/21
19. South Beach Symposium, Florida: Session Director Hair Restoration Track, 2/21
20. South Beach Symposium, Florida: Keys to Patient Satisfaction, 2/21
21. South Beach Symposium, Florida: The Female Patient, Risk Assessment and Testing. , 2/21
22. NBC News, Today in LA: “Hair Loss Strategies,” 1/21
23. Integrative Derm Soc Annual Mtg: abstract presentation Nutrafol for Menopausal women, 10/20
24. ASDS virtual annual meeting: Nutrafol for Menopausal Women. 10/20
25. ASDS virtual annual meeting: abstract presentation: DAXI for Mature Females 10/20
26. South Beach Symposium, Florida: Session Director Hair Restoration Track, 2/20
27. South Beach Symposium, Florida: Low Level Light Laser Therapy, 2/20
28. South Beach Symposium, Florida: Etiology and Pathophysiology of Hair loss. 2/20
29. South Beach Symposium, Florida: The Female Patient- Hair Loss Risk Assessment, 2/20
30. South Beach Symposium, Florida: Hair Loss Treatments-How do we choose? 2/20
31. South Beach Symposium, Florida: Keys to Patient Satisfaction, 2/20
32. South Beach Symposium, Florida: Tx Enhancements on Energy Based Microneedling, 2/20
33. KTLA 10am News: “ Hair Loss and Alopecia,” 2/20
34. KTLA 10am News: “Facials,” 1/20
35. KTLA 10am News, “ Liquid Gold for acne” 12/19
36. KTLA 10am News,: Hair loss in Men and Women,” 9/19
37. American Academy of Dermatology Annual Mtg. DC: “Hair Loss Innovations.” 3/19
38. South Beach Symposium, Florida: Session Director Hair Restoration Track, 2/19
39. South Beach Symposium, Florida: “Meeting the Needs of Hair Challenged Pt” 2/19
40. South Beach Symposium, Florida: “JAK Inhibitors” 2/19
41. South Beach Symposium, Florida: “Microneedling” 2/19
42. South Beach Symposium, Florida: “Aesthetic Tips” 2/19
43. South Beach Symposium, Florida: “Session Director Aesthetic Innovations” 2/19
44. SBS, Florida, dinner presentation, Aclaris: Seborrheic Keratosis.2/19
45. KTLA 10am News, Puberty and Product ingredients, 1/19
46. KTLA 10am News, “Winter Itch,” 12/18
47. CBS 2, Doctors Show, “Novel Lunula laser for Toenail Fungus,” 10/18
48. KTLA 10am News, “Vampire Facials.: 8/18
49. KTLA 8am News, “Shingles update,” 7/18
50. KTLA 10am News, “What’s Stressing Your Face,” 6/18
51. SCALES, Nashville “Updates on Hair Loss Treatments.” 5/18
52. South Beach Symposium, Florida: “New Updates in Hair Loss Treatments” 3/18
53. South Beach Symposium, Florida: “Aesthetic Tips” 3/18
54. South Beach Symposium, Florida: “My Favorite Things” 3/18
55. South Beach Symposium, Florida: “Session Director Aesthetic Innovations” 3/18
56. American Academy of Dermatology Mtg. San Diego: “The Hair Challenged Patient.” 2/18
57. The Aesthetic Show, Nevada: “Novel Microneedling Device” 7/17
58. SPDA Mtg, San Diego: Cosmetic Day Chair: “Cosmeceuticals,”5/17
59. SPDA Mtg, San Diego: Cosmetic Day Chair: “Advances in Adipolysis,”5/17
60. SPDA Mtg, San Diego: Cosmetic Day Chair: “Fillers and Toxins Update,”5/17
61. CBS 2, The Doctors Show: “Aerolase for Dark Skin type Acne,”5/17
62. American Academy of Dermatology Mtg. Orlando: “Treating the Hair Challenged Patient.” 3/17
63. CBS 2, Inside Edition: “Basal Cell Skin Cancers,” 2/17
64. South Beach Symposium, Florida: “Neck Rejuvenation” 2/17
65. South Beach Symposium, Florida: “Treating the Hair Challenged Pt” 2/17
66. Dove Men+Care Consultant and Speaker for launch of new product NYC, 7/16
67. The Aesthetic Show, Las Vegas, NV: “Supplementing the Hair Challenged Patient” 7/16
68. The Aesthetic Show, Nevada: “Non Thermal Low Level Light Lasers” 7/16
69. The Aesthetic Show, Nevada: “ThermiVA” 7/16
70. The Aesthetic Show, Nevada: “ThermiRF and ThermiSmooth Workshop” 7/16
71. Aesthetic TV: ThermiVa taping, 7/16
72. KCAL 9, The Doctors Show: ”What’s Stressing Your Face,”4/16
73. South Beach Symposium, Florida: “Treating the Hair Challenged Pt” 2/16
74. South Beach Symposium, Florida: “Low Level Light Lasers” 2/16
75. South Beach Symposium, Florida: “Fractional RF with Microneedling” 2/16
76. South Beach Symposium, Florida: “Injectable RF” 2/16
77. South Beach Symposium, Florida: “Vaginal Rejuvenation” 2/16
78. South Beach Symposium, Florida: “What’s New in Aesthetic Devices” 2/15
79. South Beach Symposium, Florida: “PRP and Microneedling” 2/15
80. The World Hair Congress, Miami: “All Natural Hair Supplementation,” 11/15
81. The Aesthetic Show, Newport Beach: “The Magic of Microneedling,” 11/15
82. The Aesthetic Show, Newport Beach: “Viviscal,” 11/15
83. AON Women’s Network, LA,CA:”What’s Stressing Your Face?” 10/15
84. Women’s Wellness Conference, Torrance,CA: “What’s Stressing Your Face?”10/15
85. The Aesthetic Show, Nevada: “Subdermal RF,” 7/15
86. The Aesthetic Show, Nevada: “Hair Restoration,” 7/15
87. The Aesthetic Show, Nevada: “Microneedling workshop,” 7/15
88. The Aesthetic Show, Nevada: “Thermi RF workshop,” 7/15
89. Vegas Cosmetic Surgery, Nevada: “Top 10 Melasma,” 6/15
90. Vegas Cosmetic Surgery, Nevada: “What’s on my bathroom counter,” 6/15
91. Vegas Cosmetic Surgery, Nevada: “Creating the Perfect Lip,” 6/15
92. South Beach Symposium, Florida: “Hair Supplements” 2/15
93. South Beach Symposium, Florida: “Advances in Lipolysis and Liposuction,” 2/15
94. South Beach Symposium, Florida: “Cellulite” 2/15
95. KCAL 9, The Doctors Show: “New Treatments for Acne,” 11/14
96. American Society of Cosmetic Physicians, AZ: “Prevention and Treatment of Non-surgical Complications,” 10/14
97. American Society of Cosmetic Physicians, AZ: “New Treatment Option for Melasma,” 10/14
98. KCAL 9, The Doctors Show: “Neotensil,” 10/14
99. KCAL 9, The Doctors Show: “Lasers for Hidradentits,” 914
100. Aesthetic Show, Las Vegas, NV:” Hair Loss Treatmetn,” 7/14
101. Aesthetic Show, Las Vegas, NV: “Workshop Hair Loss,” 7/14
102. KCAL 9, The Doctors Show: “Hidradentits and Acne Conglobata,” 4/14
103. KCAL 9, The Doctors Show: “Tattoo,” 4/14
104. KCAL 9, The Doctors Show: “Scar Treatments,” 3/14
105. ABC, Extra: “Forever Young BBL,” 3/14
106. South Beach Symposium, Florida: “Nanotechnology Delivery System,” 2/14
107. South Beach Symposium, Fl.: “Novel Skin Therapy Cytokines,” 2/14
108. South Beach Symposium, Fl.: “Dermatology Bread and Butter,” 2/14
109. South Beach Symposium, Fl.: “Innovations in Fat Removal,” 2/14
110. CBS 2, Doctors Show, “Boots,” 10/13
111. CBS 2, Doctors Show, “Boots,” 9/13
112. CBS 2, Entertainment Tonight, “Boots,” 8/13
113. BellaSugar.com, Internet Site: “What to Expect at a Skin Cancer Screening,” 7/13
114. Aesthetic Show, Las Vegas: “Hair Supplements,” 5/13
115. NBC 4, Nightly News 5pm, “Melafind,” 5/13
116. World Congress Hair Restoration, Edinburgh, Scotland: “Supplements for Hair Thinning,” 5/13
117. CBS 2, The Doctors Show: “Skin Secrets,” 4/13
118. CBS 2, The Talk: “Skin Care,” 4/13
119. CBS 2, The Doctors Show: “Skin Care Chest,” 4/13
120. South Beach Symposium, Florida: “Nanotechnology Delivery System,” 4/13
121. South Beach Symposium, Fl.: “Hair Supplements,” 4/13
122. South Beach Symposium, Fl.: “Dermatology Bread and Butter,” 4/13
123. South Beach Symposium, Fl.: “Innovations in Liposuction and Fat Transplant,” 4/13
124. CBS 2, The Doctors Show: “Melasma,” 3/13
125. CBS 2, The Doctors Show: “Boots,” 2/13
126. CBS 2, The Doctors Show: “Melafind,” 11/12
127. CBS 2, The Doctors Show: “Nail Disorders,” 11/12
128. CBS 2, The Doctors Show: “Underarm Rashes,” 11/12
129. UCLA Grand Rounds, “Opening a Medical Practice, “ 9/12
130. ABC, Extra: “Boots Skin Care,” 6/12
131. CBS 2, The Doctors Show: “Boots and Cysts,” 5/12
132. CBS 2, The Doctors Show: “Diet and your skin,” 4/12
133. CBS 2, The Doctors Show: “Visia photography and skin care,” 3/12
134. CBS 2, The Doctors Show: “Toenail Fungus Laser” 3/12
135. South Beach Symposium, Florida: “Nanotechnology Delivery System,” 2/12
136. South Beach Symposium, Fl.: “Dermatology Bread and Butter,” 2/12
137. South Beach Symposium, Fl.: “Hair Supplements,” 2/12
138. South Beach Symposium, Fl.: “Session Director: Fat, Cellulite and Body Sculpting,” 2/12
139. South Beach Symposium, Fl.: “Innovations in Liposuction and Fat Transplant,” 2/12
140. South Beach Symposium, Fl.: “Injectable Fat Lipolysis,” 2/12
141. CBS 2, The Doctors Show: “4 Skin Problems You Should Know About,” 2/12
142. KCAL 9, News at 2:00pm: “Hair supplements,” 1/12
143. CBS 2, The Doctors Show: “Bugs and Scalp Diseases,” 1/12
144. CBS 2, The Doctors Show: “Nail Diseases,” 1/12
145. CBS 2, The Doctors Show: “Gross Anatomy,” 12/11
146. Aesthetic Show, Las Vegas: “Topical Hyaluronic Acid with InParT Delivery,” 6/11
147. Aesthetic Show, Las Vegas: “Revale Skin Care New Products,” 6/11
148. Aesthetic Show, Las Vegas: “Water Assisted Liposuction and Transfer,” 6/11
149. World Congress of Dermatology, Korea: “Topical Hyaluronic Acid with INParT Delivery,” 5/11
150. World Congress of Dermatology, Korea: “Topical Lidocaine with InParT Delivery,” 5/11
151. KCAL 9, The Doctors Show: “Accessory Nipples,” 5/11
152. KCAL 9, The Doctors Show: “Dangerous Skin Lesions,” 2/11
153. KCAL 9, The Doctors Show: “Skin Care for All Ethnic Skin Types,” 10/10
154. KCAL 9, The Doctors Show: “Zeltiq Coolscultpting” 10/10
155. KCAL 9, The Doctors Show: “Mole Mapping, and Skin Care,” 9/10
156. PBS, Channel Beauty: “Diary of a Wrinkle,” TBD
157. CBS, Entertainment Tonight: “Skin Care,” 6/10
158. KCAL 9, The Doctors Show: “Treatment of Cellulite with Velashape,” 4/10
159. Amer Academy of Derm, Fl.: “Comparison of Botulinum Toxins,” 3,10
160. KCAL 9, The Doctors Show: “Topical Transdermal Delivery System,” 2/10
161. South Beach Symposium, Fl.: “Nanotechnology for Topical Lidocaine” 1/10
162. South Beach Symposium, Fl.: “New Cooling Device Study – Artek,” 1/10
163. South Beach Symposium, F.: “Nanotechnology for New Topical Restylane,” 1/10
164. Amer Soc for Derm Surgery, Century City, CA: “Avoiding & Treating Complications,” 12/09
165. Amer Society for Derm Surgery, Century City, CA: ,” The Future of Fillers and Toxins,” 12/09
166. 5 Continent Congress, Nice, Cote d’Azur: “Update on Mesotherapy.” 9/09
167. 5 Continent Congress, Nice, Cote d’Azur: “The Perfect Lip.” 9/09
168. Florida Derm Society, Boca Raton, FL.: “Principles and Practice of the Perfect Lip,” 5/09
169. Florida Derm Society, Boca Raton, FL.: “Sciton ProFraction,” 5/09
170. South Beach Symposium, Fl.: “Mesotherapy: is there science behind it?” 2/09
171. South Beach Symposium, Fl.: “Principles and Practice of the Perfect Lip,” 2/09
172. South Beach Symposium, Fl.: “Ten Tips to Avoid Tanking in this Economy,” 2/09
173. Oxygen Network, “Her Domain: LED Technology,” 03/09
174. International Society of Derm Surgery, Las Vegas, NV. : “LED Phototherapy,” 10/08
175. The Aesthetic Show, Las Vegas, NV. : “Shedding Light on Omnilux,” 5/08
176. Florida Derm Society, Boca Raton, Fl.: “Travel Guide to a Successful Practice,” 5/08
177. Florida Derm Society, Boca Raton, Fl.: “Periorbital Rejuvenation,” 5/08
178. Florida Derm Society, Boca Raton, Fl.: “Mesotherapy Update,” 5/08
179. Florida Derm Society, Boca Raton, Fl.: “Botulinum Toxin Complications,” 5/08
180. IMCAS, Paris, France: “LED Science and Treatments,” 1/08
181. The Aesthetic Show, Las Vegas, NV. : “LED Science and Treatments,” 5/07
182. Grand Rounds LCMHospital, Torrance, CA.: “Cosmetic and Medical Dermatol Update,” 2/07
183. Canadian Television, Insight Video: “Mesotherapy” episode, 2/07
184. Prevention Magazine Video: “Cellulite and Its Treatment” 12/06
185. Amer Soc for Derm Surgery Annual Mtg, Palm Des, CA.: “Phosphatidylcholine Update,” 10/06
186. American Acad of Dermatology Annual Mtg, San Diego, CA.: “Lower Lid Rejuvenation” 7/06
187. Amer Soc for Derm Surgery Annual Mtg, Atlanta, GA.: “Phosphatidylcholine Update,” 10/05
188. Women’s Wellness Conference, Torrance, CA.: “Less is More,” 3/05
189. Amer Acad of Dermatology Annual Mtg, New Orleans, LA : “Botulinum Toxin Update,” 2/05
190. Internatl Meso-Lipotherapy Conf, L.V., NV.: “Phosphatidylcholine: Dissolving the Myth,” 1/05
191. Intl Meso-Lipotherapy Conf Scottsdale, AZ.: “Phosphatidylcholine: Dissolving the Myth,” 9/04
192. Pacific Derm Assoc: Annual Mtg Nwpt Bch, “How to open a practice Successful Practice”, 8/04
193. ABC: Life of Luxury, Thermaphoto and Hand Rejuvenation, 11/04
194. Lifetime Television: Speaking of Women’s Health,Laser treatments of scars and birthmarks 9/04
195. Skin Disease Ed Foundation: Cosmetic Dermatology Seminar,Florida “Phosphatidylcholine: Dissolving the Myth,”  5/15/04
196. E! Entertainment/ Style Channel:  Fountain of Youth. Glynis Ablon, 4/03
197. E! Entertainment /Style Channel: Stripped. Glynis Ablon, 3/03
198. Lifetime Television:  Speaking of Women’s Health, Skin cancer update, 10/02
199. Fox Television:  The Rob Nelson Show, Botox., 9/16/02
200. E! Entertainment/ Style channel: Glow, 4/25/02
201. CBS Television:  Woman2Woman Laser Leg Vein Treatment, 8/22/01
202. CBS Television:  Woman2Woman Blu-U, 5/15/01
203. CBS Television:  Woman2Woman Botox, 5/2/01
204. CBS Television:  Woman2Woman Laser Tone Facial, 2/7/01
205. CBS Television:  Woman2Woman Pumpkin Peel, 12/5/00
206. CBS Television:  Woman2Woman Laser Hair Removal, 11/1/00
207. Fox Television Fit TV:  Fit Resort & Spa Skin Care with Dr. Glynis Ablon, 1/29/99
208. E! Entertainment Television:  Skin. Glynis Ablon, 11/98
209. South Bay Optometric Society CME:  Dermatology around the Eyes by Glynis Ablon, 11/1/98
210. Paris, France, French Academy of Dermatology annual meeting: A Comparative study of three new topical antifungal agents. Glynis Ablon, M.D., and Ted Rosen, M.D., 12/95

POSTER/Abstract PRESENTATIONS

1. Subject Satisfaction with AbobotuliumtoxinA for Moderate to Severe Glabellar Lines. Joseph, Ablon, et al. Poster AMWC 2021
2. Subject Satisfaction with AbobotuliumtoxinA for Moderate to Severe Glabellar Lines. Joseph, Ablon, et al. Poster IMCAS 2021
3. A Randomized, No Treatment Controlled, Evaluator-Blinded, Multi-Center Study to Evaluate the Effectiveness and Safety of Hard in the Chin for Augmentation and Correction of Chin Retrusion. The Aesthetic Meeting 2021
4. DaxibotulinumA for Injection Demonstrates Consistent Efficacy, Duration, and Safety in Females Independent of Age. Toxins 2021 Virtual Conf 1/21
5. A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of an Oral Supplement with Standardized Botanicals to Promote Hair Growth in Women going through Menopausal Transition ASDS Conf 10/20
6. A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of an Oral Supplement with Standardized Botanicals to Promote Hair Growth in Women going through Menopausal Transition IDS Conf 10/20
7. Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase signaling, for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies. Fall Clinical Derm Conf, Las Vegas 10/19
8. KX2-391 Ointment 1%, a Novel Dual Src/Tubulin Inhibitor, is Efficacious and Safe in the Treatment of Adults with Actinic Keratosis in Two Pivotal Phase III Studies. EADV, Madrid 9/19
9. KX2-391 Ointment 1%, a Novel Dual Src/Tubulin Inhibitor, is Efficacious and Safe in the Treatment of Adults with Actinic Keratosis in Two Pivotal Phase III Studies. AAD, DC 3/19
10. A 6-month Randomized, Double-blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women with Self-perceived Thinning Hair. SCALES Mtg, Nashville 5/18
11. A 6-month Randomized, Double-blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women with Self-perceived Thinning Hair. SBS, Miami 3/18
12. Efficacy of an Oral Supplement in Females with Self-Perceived Thinning Hair: Double-Blind, Placebo-Controlled Clinical Study Ablon, accepted for poster presentation World Congress Edinburgh, Scotland 5/13
13. Efficacy of an Oral Supplement in Females with Self-Perceived Thinning Hair: Double-Blind, Placebo-Controlled Clinical Study Ablon, accepted for poster presentation IMCAS, Paris, France 1/13.
14. Efficacy of an Oral Supplement in Females with Self-Perceived Thinning Hair: Double-Blind, Placebo-Controlled Clinical Study Ablon, ASDS, Chicago, IL 10/12
15. A Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy of Viviscal Professional Strength Oral Supplement in Females with Self-Perceived Thinning Hair, Ablon, South Beach Symposium, Miami, Florida 2/12
16. A Randomized Double-Blind, Vehicle-Controlled Pilot Study to Assess the Efficacy of Topically Applied OnabotulinumtoxinA (Botox), AbobotulinumtoxinA (Dysport) and RimabotulinumtoxinB (Myobloc) in the Treatment of Hyperhidrosis Using a Novel Transdermal Delivery System, Nestor, Ablon, South Beach Symposium, Miami,Florida 2/12
17. A Randomized, Double-Blind, Clinical Study Designed to Assess the Onset, Efficacy and Safety of AbobotulinumtoxinA (Dysport), versus OnabotulinumtoxinA (Botox) in the Treatment of Dynamic Rhytids of the Frontalis (Individual Subject Contralateral Injection Sites) Utilizing the Objectve Frrontalis Activity Measurement Standard, Nestor and Ablon, South Beach Symposium, Miami, Florida 2/12
18. Evaluation of the Efficacy and Tolerance of Transdermal (cross-linked and non-crosslinked hyaluronic acid) in the Treatment of Photodamaged Skin, Nestor, Ablon, South Beach Symposium, Miami, Florida 2/12
19. A Randomized Double-Blind, Vehicle-Controlled Pilot Study to Assess the Efficacy of Topically Applied OnabotulinumtoxinA (Botox), AbobotulinumtoxinA (Dysport) and RimabotulinumtoxinB (Myobloc) in the Treatment of Hyperhidrosis Using a Novel Transdermal Delivery System, Nestor and Ablon, World Congress of Dermatology Seoul, Korea 5/11
20. A Randomized, Double-Blind, Clinical Study Designed to Assess the Onset, Efficacy and Safety of AbobotulinumtoxinA (Dysport), versus OnabotulinumtoxinA (Botox) in the Treatment of Dynamic Rhytids of the Frontalis (Individual Subject Contralateral Injection Sites) Utilizing the Objectve Frrontalis Activity Measurement Standard, Nestor and Ablon. World Congress of Dermatology, Seoul, Korea 5/11
21. Evaluation of the Efficacy and Tolerance of Transdermal (cross-linked and non-crosslinked hyaluronic acid) in the Treatment of Photodamaged Skin, Nestor, Ablon, World Congress of Dermatology, Seoul, Korea 5/11
22. A Comparative study of three new topical antifungal agents. Glynis Ablon, M.D., and Ted Rosen, M.D., World Congress Paris, France 12/95

HONORS, AWARDS, ADVISORY BOARDS:

Sinclair US Strategic Leadership Council
Almiral Advisory Board
Aclaris Advisory Board
Leo Pharmaceutical Advisory Board
Almoral Advisory Board
Metametrix Advisory Board
Erchonia Advisory Board
Pollenium Advisory Board
Allergan Advisory Board
Galderma Advisory Board, certified trainer
Neothetics Advisory Board
Bayer Advisory Board
Thermiesthetics Advisory Board
IMCAS Research Award Jan 2010 for Botulinum Toxin Study
Voted “Top Dermatologists in California,” C Magazine 2006
Kane-King-Dodek Honor Society
Walter F. Rosenberg Award in Dermatology
Huron W Lawson Award in Obstetrics and Gynecology

EXTRACURRICULAR SOCIETY and EDITORIAL BOARD ACTIVITIES:

Beauty Tap Editorial Board 2020-present
Journal of Cosmetic Dermatology, Editorial board 2020-present
International Laser Therapy Journal, Editorial board 2019-present
Plastic and Reconstructive Journal, Editorial board 2016-present
Journal of Clinical and Aesthetic Dermatology, Editorial board 2015-present
President’s Association Board of San Diego Zoo 2015-present
Journal of Experimental Pathology, editorial board 2012-present
Dermatologic Surgery Journal Reviewer 2012-present
Photomedicine and Laser Surgery Journal Reviewer 2012-present
Skin Cancer Screening Volunteer ASDS and Skin Cancer Foundation 2005-present
Volunteer Sturg-Weber Foundation2011-present
Volunteer physician IraqStar 2009-present
Skin Cancer Foundation, member and volunteer 2005- present
American Society of Dermatologic Surgery 2003-present
Pacific Dermatologic Society, member1999-2009
American Assoc. for Sexually Transmitted Dz, member 1999-present, STD Task Force 1995-1996
Los Angeles Youth Network charity 1998-2006
Los Angeles Metropolitan Dermatologic Society, member 1998-present
Academy of Lipo-Suction Surgery, fellow 1997-present
American Academy of Dermatology, fellow 1993-present
American Society for Laser Medicine and Surgery, Inc, fellow 1995-present
Women's Dermatology Society, 1995-present
Medical Director Skin Cancer Screening, Medical Institute Little Co. of Mary, 2000-present
Women's water Polo team, Pomona College 1984-1988

HOBBIES AND INTERESTS:

Dance instructor and choreographer, speed jump-roping, karate, horseback riding, water-skiing, travel, French, scuba diving, and boxing. Teaching, lecturing, and charity work.